SPARC and thyroid cancer: MiR-211 is confirmed to inhibit cells proliferation in thyroid cancer 26 and cervical cancer 38 by regulating secreted protein acidic and rich in cysteine (SPARC), which is an extracellular matrix glycoprotein.